Does coffee boost longevity? 47,000 women were studied for 30 years to find out
Drinking moderate amounts of coffee in midlife may boost healthy aging decades later, according to a study presented this week at the annual meeting of the American Society for Nutrition.
The findings add to the existing body of research showing there may be health and longevity benefits to consuming coffee. Most of these studies are observational and do not directly show that consuming coffee necessarily causes better health, just that people who drink coffee often tend to be healthier — as measured by such metrics as lower cardiovascular mortality, lower risk of some cancers and lower risk of Type 2 diabetes.
The analysis, which followed more than 47,000 women over about 30 years, found that those who drank coffee during midlife, ages 45 to 60, were more likely to exhibit healthy aging later in life. On average, they consumed 315 milligrams of caffeine a day, the equivalent to about three small cups of coffee.
The researchers defined healthy aging as being at least 70 years old and free from 11 major chronic diseases — including heart disease, Type 2 diabetes, cancer and Parkinson's disease — with no major mental health or cognitive impairment or memory problems.
The study followed female nurses starting in 1984 and asked them to fill out questionnaires about their consumption of coffee, tea and soda. By 2016, about 3,700 women were considered part of the healthy aging group. Within that group, each extra cup of coffee a day was linked to a 2% to 5% higher chance of doing well later in life, up to five small cups a day.
The same link between coffee consumption and better health in later life was not found among women who drank tea, soda or decaffeinated coffee.
'While past studies have linked coffee to individual health outcomes, our study is the first to assess coffee's impact across multiple domains of aging over three decades,' Sara Mahdavi, an adjunct professor of nutritional sciences at the University of Toronto who led the study, said in a statement. 'The findings suggest that caffeinated coffee — not tea or decaf — may uniquely support aging trajectories that preserve both mental and physical function.'
The study did not examine why caffeinated coffee and not other caffeinated beverages was linked to healthy aging. But previous research suggests that coffee contains antioxidants like polyphenols, which may help the body lower inflammation, reduce oxidative stress on cells and fight diseases.
The analysis accounted for other factors that influence healthy aging including body weight, smoking, alcohol use, physical activity, education level and protein in the diet.
'The takeaway is not that people should start drinking coffee for the sake of longevity, nor that more is better,' Mahdavi said. 'What we found is that moderate caffeinated coffee consumption — approximately 1 to 3 cups per day — was associated with a modestly higher likelihood of healthy aging over time.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
3 days ago
- CNBC
Harvard study of nearly 50,000 women over 30 years finds coffee drinking linked to healthy aging, longevity: It seems to offer 'protective benefits'
Coffee, and whether or not it's good for you, has been a research focus for decades. A regular cup or two has been linked to better heart health, a longer life, and most recently, a study led by a Harvard researcher, Dr. Sara Mahdavi found that drinking coffee may even aid healthy aging in women. "The findings suggest that caffeinated coffee—not tea or decaf—may uniquely support aging trajectories that preserve both mental and physical function," said Mahdavi, a postdoctoral fellow at Harvard T.H. Chan School of Public Health. The paper, which was presented at the American Society of Nutrition's annual meeting, has not yet been published or peer-reviewed. But the findings are robust. Researchers followed 47,513 women over the course of decades, starting in 1984, and analyzed their health data and coffee-drinking habits. By 2016, only 3,706 participants were considered healthy agers. Factors that the researchers considered to define healthy aging were: The researchers considered additional lifestyle factors like smoking, exercise frequency and diet, and adjusted for their contribution to health outcomes. Participants were also asked to share how often they drank coffee, tea and either Coca-Cola or Pepsi, which can all be sources of caffeine. Women who had at least one cup of coffee daily were more likely to be among the healthy agers, the study found. Of the healthy agers, each extra cup of coffee they had each day was associated with a 2% to 5% increased chance of aging well, peaking at about five small cups a day. Drinking tea or decaffeinated coffee didn't have a clear connection to healthy aging in the study, and drinking cola drastically lowered chances of positive health outcomes. How much coffee per day leads to healthy aging is debatable. Mahdavi says drinking up to seven small cups of coffee daily was associated with healthy aging in the study, but whether or not that amount is healthy can shift depending on the person. Other recent studies have pointed to the potential health benefits of drinking coffee. A recent study of nearly 50,000 U.S. adults published this May found that having one to three cups of coffee a day could lower a person's chances of dying by around 15% within the following nine to 11 years, in comparison to those who didn't consume the drink. "Moderate coffee intake may offer some protective benefits when combined with other healthy behaviors such as regular exercise, a healthy diet and avoiding smoking," Mahdavi said in a press release. "While this study adds to prior evidence suggesting coffee intake may be linked with healthy aging, the benefits from coffee are relatively modest compared to the impact of overall healthy lifestyle habits and warrant further investigation."
Medscape
4 days ago
- Medscape
Diabetes Plus Asthma Equals Greater Metabolic Risk
People with both diabetes and asthma appear to face greater metabolic risks than those with either condition alone, according to new observational data. In a study of more than 18,000 participants from the National Health and Nutrition Examination Survey during 2001-2020, individuals with both asthma and diabetes (most presumed to have type 2 diabetes) had significantly greater impairments in glucose regulation, insulin sensitivity, and lipid metabolism compared with those who had only one condition alone or neither. Inflammatory markers C-reactive protein (CRP) and high-sensitivity CRP (hs-CRP) were also elevated in the comorbid group, 'supporting a hypothesis of a shared inflammatory mechanism,' Sixtus Aguree, PhD, assistant professor at the Indiana University School of Public Health-Bloomington, and colleagues wrote in a poster presented at NUTRITION 2025, the annual meeting of the American Society for Nutrition. The findings 'emphasize the need for integrated clinical strategies that simultaneously target both inflammation and metabolic dysfunction in patients with asthma-diabetes comorbidity,' the authors wrote. 'Routine screening for insulin resistance and inflammatory markers in [these] patients may aid in early intervention and risk reduction.' This points to the need for integrated clinical care, Aguree told Medscape Medical News . 'For managing these comorbid conditions, healthcare professionals need to work together. I think that's a better way to treat the person than working in silos.' Bidirectional Relationship Commenting on the findings, Tianshi David Wu, MD, assistant professor of pulmonary and critical care at Baylor College of Medicine in Houston, told Medscape Medical News that these findings align with current evidence. 'Diabetes and asthma have a bidirectional relationship,' Wu explained. 'Population studies have shown that patients with diabetes are at higher risk of developing asthma later on, and vice versa. What's still unknown are the mechanisms that explain this finding.' Wu added that the researchers had put forth a reasonable hypothesis — that systemic inflammation may play a key role in this association. 'The best way to prove this would be with a trial that specifically targets the type of inflammation you think is driving both asthma and diabetes to see how it affects these conditions.' As a possible blueprint, he pointed to cardiology, where patients with heart failure and diabetes are preferentially treated with sodium-glucose cotransporter-2 inhibitors, which are effective at treating both conditions. 'In the asthma world, I don't think the evidence is there yet to recommend any specific diabetes medication, but there is plenty of real-world data suggesting some benefit, and there are two clinical trials ongoing testing semaglutide and metformin to see if they can improve asthma,' Wu said. Surprising Impact on Insulin Resistance The study included 18,370 nationally representative US adults. Among them, 8.2% had diabetes without asthma, 7.4% had asthma without diabetes, 83.3% had neither (controls), and 1.2% had both. BMI was highest in the combined asthma-diabetes group (35.9 kg/m2 vs. 28.2 kg/m2 in controls, P < .001), as was waist circumference (117.6 cm vs. 97.3 cm, P < .001). Insulin resistance, defined as a homeostasis model assessment of insulin resistance (HOMA-IR) > 2.5, was present in 41% of controls, 46.8% with asthma only, 77.3% with diabetes only, and 85.6% with both conditions. The HOMA-IR score in the asthma-diabetes group was significantly higher than in controls (9.85 vs. 2.96, P < .001). Logistic regression analysis confirmed that the odds of insulin resistance were nearly eight times higher in the asthma-diabetes group than in the control group (odds ratio [OR], 7.89, P < .001), even after adjusting for BMI, sex, and medication use. 'We didn't expect insulin resistance to be that much higher in the combination of asthma and diabetes. That shocked us,' Aguree said. Asthma alone was not significantly associated with insulin resistance (OR, 0.76, P = .220), 'underscoring the additive impact of coexisting diabetes,' the authors wrote in their poster. Additional Metabolic Outcomes Absolute values of LDL cholesterol were 115.9 mg/dL and 114.5 mg/dL, respectively, for controls and asthma only, vs 98.9 mg/dL and 104.8 mg/dL for diabetes only and asthma-diabetes groups, respectively. The lower value in those with diabetes is likely due to greater use of statins, Aguree noted. In contrast, compared with controls, those in the asthma-diabetes group had significantly lower levels of HDL cholesterol, while triglycerides and the triglyceride/HDL ratio were higher ( P < .001 for all). Systolic blood pressure was also significantly higher in the comorbid group ( P < .001), as was diastolic blood pressure, although to a lesser extent ( P = .012). A1c levels were 5.41% in controls and 5.46% in the asthma-only group, both significantly lower than levels in the diabetes group (7.34%) and the comorbid group (7.11%), Aguree said. Log-CRP values were 0.530 units higher in the asthma-diabetes group than in controls ( P < .001), as were hs-CRP (1.70 mg/L vs 0.60 mg/L, P < .001). Aguree and colleagues are now expanding their analysis to include longitudinal data and evaluate integrated interventions, such as combined anti-inflammatory and glucose-lowering medications, as a means of reducing the burden of both conditions. Aguree had no disclosures. Wu declared receiving funding from the National Institutes of Health and the American Lung Association.
Yahoo
4 days ago
- Yahoo
Rare exoplanet discovered in outskirts of the Milky Way
Astronomers have located a rare exoplanet on the edge of the Milky Way. The exoplanet, a gas giant named AT2021uey b, orbits a low-mass star and is located about 3,200 light-years away from Earth, according to a paper published last month in the journal Astronomy & Astrophysics. Its orbit around an M dwarf star -- a relatively small and cool star -- completes every 4,170 days. MORE: Exoplanet discovered in 2020 has the coldest temperatures ever measured, scientists say The researchers used a technique known as gravitational microlensing -- a method based on Albert Einstein's theory of general relativity -- to locate the planet. The presence of mass warps the fabric of space-time, similar to how a bowling ball would make a dent when placed on a trampoline, according to NASA. The effect is extreme around "very massive" objects, such as black holes and galaxies, but stars and planets can also cause a detectable degree of warping. The new exoplanet's mass is estimated to be slightly greater than Jupiter's, the researchers said. The unusual size ratio to the star it orbits led to its discovery, as detecting an Earth-type planet would have been "much more difficult," according to a press release by Vilnius University in Lithuania. Gravitational microlensing is a "rare phenomenon," the researchers said. There have only been three such cases of a planet being documented by microlensing in the history of observations, the researchers said. Astronomers search for a temporary light "pulsation" when analyzing a vast amount of data. The vast majority of observed stars -- about 90% -- pulsate for "various other reasons," with a minority of cases actually showing the microlensing effect, Marius Maskoliūna, an astronomy and astrophysics researcher at Vilnius University and co-author of the study, said in a statement. "This kind of work requires a lot of expertise, patience, and, frankly, a bit of luck," Maskoliūna said. "You have to wait for a long time for the source star and the lensing object to align and then check an enormous amount of data." MORE: Could our solar system have 9 planets after all? Astronomers may have confirmed possible existence. In addition, most microlensing efforts are recorded at the Galactic Center -- the densest part of the Milky Way, Edita Stonkutė, an associate professor of astronomy at Vilnius University, said in a statement. AT2021uey b was found quote far from the center, in the "galactic halo, on the outskirts of the galaxy, she said. "This is only the third planet in observational history to be discovered so far from the Galactic bulge," Stonkutė said. The microlensing technique is promising because it allows the detection of the "unexpected or even invisible," the researchers said. "What fascinates me about this method is that it can detect those invisible bodies," Maskoliūna said. In collaboration with researchers from the Astronomical Observatory of the University of Warsaw, the researchers analyzed data from the European Space Agency's "Gaia" telescope and supplemented it with ground-based observations from telescopes at the Vilnius University's Molėtai Astronomical Observatory. MORE: How astronomers used gravitational lensing to discover 44 new stars in distant galaxy The microlensing phenomenon was first spotted in 2021, which led the astronomers on a yearslong journey to "carefully" verify the existence of the new exoplanet, according to the release. The first discovery of an exoplanet orbiting a star was made in 1995, the researchers said. Since then, more than 6,000 exoplanets have been confirmed. However, the science is still considered "relatively young," the researchers said. "As data accumulated, we learned that many types of planetary systems are completely unlike ours -- the Solar System," Stonkutė said. "We've had to rethink planetary formation models more than once."
